Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28668386

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Aug
First author
Chiappella A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Aug;18(8):989-991. doi: 10.1016/S1470-2045(17)30467-9.
    note
    Source null
    related pmid
    28759369
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Oct;18(10):e557. doi: 10.1016/S1470-2045(17)30706-4.
    note
    Source null
    related pmid
    28971816
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2017 Oct;18(10):e558. doi: 10.1016/S1470-2045(17)30702-7.
    note
    Source null
    related pmid
    28971817
    relationship
    Comment in

Authors and identifiers

  1. name
    Chiappella A
    type
    Author
  2. name
    Martelli M
    type
    Author
  3. name
    Angelucci E
    type
    Author
  4. name
    Brusamolino E
    type
    Author
  5. name
    Evangelista A
    type
    Author
  6. name
    Carella AM
    type
    Author
  7. name
    Stelitano C
    type
    Author
  8. name
    Rossi G
    type
    Author
  9. name
    Balzarotti M
    type
    Author
  10. name
    Merli F
    type
    Author
  11. name
    Gaidano G
    type
    Author
  12. name
    Pavone V
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Chiappella A
    type
    Author
  2. name
    Martelli M
    type
    Author
  3. name
    Angelucci E
    type
    Author
  4. name
    Brusamolino E
    type
    Author
  5. name
    Evangelista A
    type
    Author
  6. name
    Carella AM
    type
    Author
  7. name
    Stelitano C
    type
    Author
  8. name
    Rossi G
    type
    Author
  9. name
    Balzarotti M
    type
    Author
  10. name
    Merli F
    type
    Author
  11. name
    Gaidano G
    type
    Author
  12. name
    Pavone V
    type
    Author
bibliography ids
  1. nci-bib-75dc34308ddfa50d714ad67a
book metadata
content sha256
6431977a142a58716a55c0fbad1fe7a1e8dbe962fe032ab6c8b3f0de5e2c7835
document type
citation
dois
  1. 10.1016/S1470-2045(17)30444-8
electronic publication date
display
2017 Jun 28
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28668386
immutable id
pubmed:28668386@6431977a142a58716a55c0fbad1fe7a1e8dbe962fe032ab6c8b3f0de5e2c7835
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
1076-1088
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Aug;18(8):989-991. doi: 10.1016/S1470-2045(17)30467-9.
    note
    Source null
    related pmid
    28759369
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Oct;18(10):e557. doi: 10.1016/S1470-2045(17)30706-4.
    note
    Source null
    related pmid
    28971816
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2017 Oct;18(10):e558. doi: 10.1016/S1470-2045(17)30702-7.
    note
    Source null
    related pmid
    28971817
    relationship
    Comment in
outcomes validated
false
pmid
28668386
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
3df99f6586361015049b9b4195bf58aa5ef0cc91b369cfa5c36425db9075ca49
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Aug
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28668386/
title
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.

Preserved source evidence · Independent clinical review pending · Not medical advice